SALT LAKE CITY, June 26, 2012 /PRNewswire/ -- Remedy Informatics, the leading provider of registries for healthcare and life sciences, announced today that Tarek El-Sadany, Ph.D., and Manish Muzumdar have joined the company's executive team. Both will play key leadership roles as Remedy continues to grow its technology lead in the translational and clinical informatics technology market. Their focus will be to enhance and deliver the company's Mosaic™ Platform, clinical and research informatics products and systems, and customer solutions to solve present and future data challenges that customers face. Dr. El-Sadany will serve as Executive Vice President of Technology while Muzumdar serves as Senior Vice President of Products.
(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)
Remedy's new office in Menlo Park will house product and software development teams and complement Remedy's skilled technology staff with new and experienced talent from the heart of Silicon Valley.
Both El-Sadany and Muzumdar have extensive backgrounds in technology, platform, and product development. Each has held leadership roles delivering enterprise solutions for global companies across vertical industries, including healthcare, financial services and insurance. Dr. El-Sadany served as vice president of global product support at Oracle with Muzumdar on his team, and they have worked together on several successful ventures. El-Sadany recently filled a senior role in the Egyptian government with responsibility for growing the country's IT industry. With the pressing and growing need to deliver transformative information technology solutions for healthcare, El-Sadany and Muzumdar bring a successful track record of innovation while delivering technology platforms and products to address critical challenges and capture vital opportunities at premier institutions around the world.
Remedy continues to grow its line of products and systems all built on its flagship Mosaic Platform. New products include RemedyJoint™, InvestigateCT™, SpecimenTrack™, and ComprehensiveBMT™, with more to come before the year's end. Remedy has also extended its growing list of notable clients by signing deals with the Cleveland Clinic's world-renowned Heart and Vascular Institute, the Jewish Hospital-Mercy Health Blood and Marrow Transplant Center, the American Joint Replacement Registry (AJRR) and the Huntsman Cancer Institute.
"We've reached a tipping point with our technology and Tarek and Manish – two of the brightest and most experienced technology executives I have worked with – have the expertise to propel us to the next level," said Gary Kennedy, Founder and CEO of Remedy Informatics. "Our products and systems fill a technology gap where no one has really innovated effectively, and as a result we're seeing tremendous demand for our products. The secret, I think, has been to take advancements and innovations from other industries with similar information challenges and apply them appropriately to various segments within the life sciences. As such, I anticipate that Tarek and Manish will have an immediate and positive impact."
For information about Remedy's leading registry technology, or to request a demonstration, please visit our website, www.remedyinformatics.com.
About Remedy Informatics, Inc.
Remedy Informatics, Inc. is the leading provider of clinical registries, medical research software, and research informatics products that accelerate translational medicine discoveries from bench to bedside. Remedy offers a wide range of highly configurable biomedical informatics products that are built on the powerful Mosaic™ Platform. Remedy's mission is to tangibly, measurably and permanently improve the effectiveness of Life Science and Healthcare Research in the United States and around the world. For more information visit: www.remedyinformatics.com.
Media Contacts
Kristofer Beldin, Remedy Informatics, (801) 733-3335 (office)/(801) 870-9407 (cell), [email protected]
SOURCE Remedy Informatics, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article